Immix Biopharma Inc Stock (IMMX) Forecast
The Immix Biopharma Inc (IMMX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $7.12, representing a -1.12% decrease from the current price of $7.20. The highest analyst price target is $8.03, and the lowest is $6.21.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month IMMX Price Target
Average 5.78 (-19.67% Downside)
Is Immix Biopharma Inc (IMMX) A Buy Now?
Oscillators
Buy: 3 · Sell: 1 · Neutral: 3Summary: Neutral
Moving Averages
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell
According to our latest analysis, IMMX could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on IMMX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.44 indicates that IMMX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 17.99 indicates that IMMX is oversold. This indicates that IMMX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 45.58 indicates that IMMX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of 41.33 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
- CCI (Commodity Channel Index): A CCI(14) value of -74.00 indicates that IMMX is still oversold but not to an extreme extent.
Long-term IMMX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Immix Biopharma Inc financial reports and earnings history, Immix Biopharma Inc (IMMX) stock could reach $6.70 by 2030, $17.23 by 2040 and $21.18 by 2050. See the projected annual prices until 2050 of the Immix Biopharma Inc stock below:
- Immix Biopharma Inc (IMMX) is expected to reach an average price of $8.67 in 2035, with a high prediction of $9.54 and a low estimate of $8.00. This indicates an +20.42% change from the last recorded price of $7.20.
- Immix Biopharma Inc (IMMX) stock is projected to chart a bullish course in 2040, with an average price target of $11.81, representing an +63.96% change from its current level. The forecast ranges from a conservative $11.36 to a sky-high $17.23.
- Our analysts predict Immix Biopharma Inc (IMMX) to change +111.61% by 2045, soaring from $13.81 to an average price of $15.24, potentially reaching $20.39. While $13.81 is the low estimate, the potential upside is significant.
- Immix Biopharma Inc (IMMX) stock is expected to climb by 2050, reaching an average of $20.55, a +185.47% change from its current level. However, a wide range of estimates exists, with high and low targets of $21.18 and $16.40, respectively, highlighting the market's uncertainty.
Immix Biopharma Inc Stock (IMMX) Year by Year Forecast
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2026
The predicted value for Immix Biopharma Inc (IMMX) in 2026 is set at an average of $8.71. Estimates vary from a peak of $15.10 to a trough of $4.18, indicating an +20.90% surge from the present price of $7.20.
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Immix Biopharma Inc (IMMX) is $4.66, with a high forecast of $6.18 and a low forecast of $3.54. This indicates an -35.32% decrease from the last price of $7.20.
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2028
In 2028, Immix Biopharma Inc (IMMX) is projected to reach an average price of $5.49, with a high projection of $7.92 and a low estimate of $4.40. This indicates an -23.80% fall from the last price of $7.20.
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2029
The 2029 price forecast for Immix Biopharma Inc Stock (IMMX) is $6.36 on average, with a high prediction of $10.91 and a low estimate of $4.63. This represents an -11.72% decrease from the previous price of $7.20.
Immix Biopharma Inc Stock (IMMX) Price Forecast for 2030
Immix Biopharma Inc Stock (IMMX) is expected to reach an average price of $5.59 in 2030, with a high forecast of $6.70 and a low forecast of $4.74. This signifies an -22.34% decrease from the last price of $7.20.
